ACL Graft Market – Global Forecast To 2029
膝前十字靭帯(ACL)再建術市場 – ACL手術の種類(再建、再置換)、年齢(19歳以上・19歳未満)、性別(男性、女性)、傷害[スポーツ傷害(バスケットボール、フットボール)、スポーツ以外の傷害(交通事故、転倒)]、エンドユーザー – 2029年までの世界予測
ACL Graft Market by Type of ACL Surgery (Reconstruction, Revision), Age (Above & Below 19 years), Gender (Male, Female), Injury (Sports Injuries (Basketball, Football), Non-sports Injuries (Road Accidents, Falls)), End User – Global Forecast to 2029
The global ACL graft market is projected to reach 0.18 billion by 2029 from USD 0.12 billion in 2024, at a CAGR of 7.2% during the forecast period.
世界の膝前十字靭帯(ACL)再建術市場は、予測期間中のCAGR 7.2%で、2024年の1億2,000万米ドルから2029年までに1億8,000万米ドルに達すると予測されています。
Lists of Companies Profiled in the Report:
RTI Surgical (US), AlloSource (US), Arthrex, Inc. (US), LifeNet Health (US), Bone Bank Allografts (US), MTF Biologics (US), Parametrics Medical (US), and JRF Ortho (US).
The report provides insights on the following pointers:
- Analysis of key drivers: (Rise in the aging population that is more susceptible to orthopedic complications, increase in sports and accident-related injuries, and the rising awareness about ACL injuries along with advancements in surgical techniques and improved graft materials), restraints (High cost of ACL reconstruction surgery, and Risks associated with ACL graft surgery), opportunities (Favourable government initiatives and improved insurance coverage for ACL surgeries, and expansion of healthcare facilities & increased healthcare expenditure), and challenges (Need for skilled professionals, discrepancies in the availability of insurance for ACL Surgeries, and regulatory Hurdles for new medical devices and graft materials) influencing the growth of the in ACL graft market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the ACL graft market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ACL graft market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like RTI Surgical (US), AlloSource (US), MTF Biologics (US), Arthrex, Inc. (US), and LifeNet Health (US) are among others, in the ACL graft market strategies.